Israel: Bar-Ilan University develops molecular strategy to treat hematological cancer
The study could provide an answer to types of hematological cancers for which no treatment has yet been found
Researchers at Bar-Ilan University in Israel have unveiled a new therapeutic approach in the fight against hematological cancer.
The new method, developed by Professor Mira Barda-Saad and her research team at the Mina and Everard Goodman Faculty of Life Sciences, involves attacking the cytoskeleton protein, called WASp, which has a unique structural condition in active hematological cancer cells.
To the article>>>